Acutus Medical, Inc.
AFIB · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $3 | $1 | $5 |
| - Cash | $14 | $13 | $13 | $18 |
| + Debt | $36 | $36 | $36 | $38 |
| Enterprise Value | $23 | $26 | $23 | $25 |
| Revenue | $7 | $5 | $4 | $4 |
| % Growth | 35.6% | 27.6% | 13.8% | – |
| Gross Profit | $1 | $0 | -$0 | -$0 |
| % Margin | 14.1% | 7.1% | -8.3% | -0.8% |
| EBITDA | $0 | $1 | $1 | -$0 |
| % Margin | 4.5% | 15.9% | 34% | -8.6% |
| Net Income | -$1 | -$6 | -$1 | -$2 |
| % Margin | -19.7% | -106.5% | -22.1% | -44.7% |
| EPS Diluted | -0.047 | -0.19 | -0.031 | -0.055 |
| % Growth | 75.3% | -516.9% | 43.6% | – |
| Operating Cash Flow | -$4 | -$4 | -$7 | -$17 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$4 | -$7 | -$17 |